A team at UCLH, UCL and Mercedes-AMG High Performance Powertrains who developed a Continuous Positive Airway Pressure (CPAP) breathing aid now used in hospitals across the UK have received an award from the Royal Academy of Engineering for exceptional services during a pandemic.
A cancer drug trialled for the first time in the world at the UCLH Clinical Research Facility (CRF) has been approved for use in patients in the United States.
Researchers from UCLH, UCL and the University of East Anglia have highlighted the need to identify, test and isolate healthcare workers who experience a new loss of taste or smell (anosmia).
Scientists at a new UCL centre will use tools such as machine learning to analyse intensive care data from two London hospitals to find clues that will improve the care of critically ill adults and babies.
UCLH and UCL researchers are working with Microsoft to see if chest imaging data can identify better who should shield in potential future COVID-19 outbreaks.
Researchers have highlighted the importance of routinely screening healthcare staff for the SARS-CoV-2 virus after finding a high proportion of front-facing staff had the virus during the peak of the pandemic.
Patients with COVID-19 will be given the cystic fibrosis drug ‘Dornase alfa’ to determine if it can help improve survival by reducing excess inflammation in the lungs, as part of a trial co-led by UCL and the Francis Crick Institute.
Stroke patients who should be calling an ambulance appear to have stayed at home during the Covid-19 outbreak, according to an analysis by researchers who urged anyone who thinks they may be having a stroke.
UCLH teams were crucial to a large, international research study published in The Lancet over the weekend that is set to change guidelines around the treatment of gastrointestinal (GI) bleeding.
